Peter Holme Jensen
Director/Board Member bei AQUAPORIN A/S
Vermögen: 987 102 $ am 31.03.2024
Profil
Peter Holme Jensen founded ENKAM Pharmaceuticals A in 2000 and Aquaporin A in 2005, where he held the title of Chief Innovation Officer.
Dr. Jensen is also the founder of Silico Pharma ApS.
Currently, he is the Director at InnovationsFonden, Aquaporin Space Alliance ApS, and Aquaporin A.
Dr. Jensen obtained a doctorate degree from the University of Copenhagen and a graduate degree from the University of Southern Denmark.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AQUAPORIN A/S
1,92% | 31.12.2022 | 210 659 ( 1,92% ) | 987 102 $ | 31.03.2024 |
Aktive Positionen von Peter Holme Jensen
| Unternehmen | Position | Beginn |
|---|---|---|
| AQUAPORIN A/S | Director/Board Member | 29.04.2024 |
| Silico Pharma ApS | Founder | 14.04.2010 |
Aquaporin Space Alliance ApS
 Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | Director/Board Member | - |
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Ehemalige bekannte Positionen von Peter Holme Jensen
| Unternehmen | Position | Ende |
|---|---|---|
| AQUAPORIN A/S | Chief Executive Officer | 01.01.2022 |
ENKAM Pharmaceuticals A/S
 ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Founder | 09.12.2008 |
Ausbildung von Peter Holme Jensen
| University of Copenhagen | Doctorate Degree |
| University of Southern Denmark | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AQUAPORIN A/S | Producer Manufacturing |
| Private Unternehmen | 4 |
|---|---|
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Silico Pharma ApS | |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Finance |
Aquaporin Space Alliance ApS
Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | Electronic Technology |
